Other Financial Statement Information (Tables)

6 Months Ended

Jun. 30, 2026

Other Financial Statement Information [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following (in thousands):


		June 30, 2026				December 31, 2025
Prepaid drug manufacturing costs		$	9,978			$	1,637
Interest income receivable			3,928				3,285
Prepaid clinical trial costs			2,930				3,435
Prepaid commercial planning costs			2,562				359
Prepaid software costs			2,448				1,669
Prepaid medical affairs costs			2,277				486
Other			4,209				3,423
Total prepaid expenses and other current assets		$	28,332			$	14,294

Schedule of Other Noncurrent Assets

Other noncurrent assets consist of the following (in thousands):


		June 30, 2026				December 31, 2025
Operating lease right-of-use assets		$	1,687			$	1,923
Deferred debt issuance costs			1,578				2,473
Property and equipment, net			813				1,374
Internal-use software			800				—
Other			613				80
Total other noncurrent assets		$	5,491			$	5,850

Schedule of Accrued Expenses And Other Current Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):


		June 30, 2026				December 31, 2025
Accrued payroll		$	12,151			$	18,700
Accrued drug manufacturing costs			10,283				8,427
Accrued commercial planning expenses			4,452				1,181
Accrued clinical trial costs			4,131				1,333
Other			2,731				1,916
Total accrued expenses and other current liabilities		$	33,748			$	31,557